Doximity, Inc.
Reads like this one publish minutes after the filing lands on EDGAR. Get them as JSON over the API or inside your AI agent over MCP.
Doximity, Inc. (DOCS) filed an SEC Form 8-K — Submission of Matters to a Vote of Security Holders. Item 5.07 Submission of Matters to a Vote of Security Holders. On August 27, 2026, Doximity, Inc. (the “Company”) held its 2026 Annual Meeting of Stockholders (the “Annual Meeting”). At the Annual Meeting, the Company’s stockholders voted on the three proposals outlined in the Co
Doximity (DOCS) director Kira Wampler plans to sell 2,000 shares, valued at $52,660, under Rule 144 after exercising stock options. This follows a similar sale of 2,000 shares in August 2026. Doximity has 127.3 million shares outstanding.
Doximity insider Sitaram executed and sold portions of $4.12 options and had RSU withholding in August, described as routine. The article links a higher GAAP effective tax rate (about 40% vs 17% a year earlier) to equity-compensation taxation, contributing to GAAP EPS $0.13 vs non-GAAP $0.29. It also notes AI search revenue was not recognized in the June quarter, with gross margin 87.5% vs 91.2%.
Over the past 7 days, alphai's AI scored 2 news stories mentioning DOCS (Doximity, Inc.). Coverage has been balanced: 0 bullish, 2 neutral, and 0 bearish.
Recent DOCS coverage spans earnings, financial news and corporate actions.
In the last 30 days, DOCS insiders filed 4 SEC Form 4 transactions — no purchases and 4 sales ($440K). The most active reporter was Wampler Kira Scherer with 2 filings. 100% of those filings were made under pre-arranged Rule 10b5-1 plans.
The filing confirms routine governance outcomes with no material change to the business.
A small insider sale that adds modest supply to the market.
Insider selling tied to routine option/RSU mechanics, but the piece highlights a widening GAAP vs non-GAAP earnings gap driven by tax rate and AI search revenue recognition.
Price action is framed as macro-driven rather than DOCS fundamentals changing.
Guidance raise plus accelerating AI usage metrics (workflow prescribers, prompt volume, AI scribe adoption) supports a bullish re-rating, but margin pressure from higher AI compute is a key offset.
alphai scores every news story that mentions DOCS with an AI model for sentiment and relevance, and aggregates insider trades from Doximity, Inc.'s SEC EDGAR Form 4 filings. Figures refresh continuously.
Doximity, Inc. (DOCS) filed an SEC Form 8-K — Submission of Matters to a Vote of Security Holders. Item 5.07 Submission of Matters to a Vote of Security Holders. On August 27, 2026, Doximity, Inc. (the “Company”) held its 2026 Annual Meeting of Stockholders (the “Annual Meeting”). At the Annual Meeting, the Company’s stockholders voted on the three proposals outlined in the Co
1 min readDoximity (DOCS) director Kira Wampler plans to sell 2,000 shares, valued at $52,660, under Rule 144 after exercising stock options. This follows a similar sale of 2,000 shares in August 2026. Doximity has 127.3 million shares outstanding.
2 min readDoximity insider Sitaram executed and sold portions of $4.12 options and had RSU withholding in August, described as routine. The article links a higher GAAP effective tax rate (about 40% vs 17% a year earlier) to equity-compensation taxation, contributing to GAAP EPS $0.13 vs non-GAAP $0.29. It also notes AI search revenue was not recognized in the June quarter, with gross margin 87.5% vs 91.2%.
4 min readAfter July Producer Price Index came in flat month over month, below expectations, and earlier CPI showed 0.1% monthly growth with annual inflation cooling to 3.4%, several software stocks rose. The article cites Rapid7 (RPD) up 3.6%, Tenable (TENB) up 3.2%, Marqeta (MQ) up 1.1%, Doximity (DOCS) up 0.3%, and 8x8 (EGHT) up 0.2%.
4 min readDoximity (DOCS) reported Q1 2027 revenue of $156.6 million, up 7% year over year, and adjusted EBITDA of $74.8 million. The company raised full-year 2027 revenue guidance to $671 million to $681 million. It said AI workflow and scribe usage grew, repurchased $91.6 million of stock, and ended June 30 with $688 million in cash and marketable securities.
6 min readDoximity (NYSE:DOCS) reported Q1 revenue of $156.62M, up from $145.91M, but net income fell to $24.32M from $53.32M. The company guided for Q2 revenue of $170–$171M and full-year revenue of $671–$681M, citing AI clinical tool adoption and enterprise AI client wins.
5 min readDoximity (NYSE:DOCS) reported fiscal Q1 revenue of $156.6M, up 7% year over year, while GAAP net income fell to $24.3M. The company said workflow active prescribers grew over 30% YoY and AI Search queries rose more than 25% QoQ. It raised FY2027 revenue guidance to $671M-$681M. Analysts’ price targets range from $18 to $47.
5 min readDoximity (DOCS) reported Q1 FY2027 revenue of $156.6 million, up 7% year over year, with adjusted EBITDA of $74.8 million. The company raised full-year 2027 revenue guidance to $671 million to $681 million and adjusted EBITDA guidance to $309 million to $329 million. It also repurchased $91.6 million of stock and ended June 30 with $688 million cash and marketable securities.
7 min readDoximity (NYSE:DOCS) shares surged after its fiscal Q1 report on Aug. 7, rising to an intraday high near $40 and closing up 32.6% at $27.40, after CEO Jeffrey Tangney said its AI Search has unit economics generating over 10x its operating cost. Results showed 7% YoY revenue to $156.6M, EPS $0.29, but net income -54% and free cash flow -34%.
6 min readTruist Securities raised its Doximity (NYSE:DOCS) price target to $24 from $19 and kept a Hold rating after the stock rose 0.46% premarket. Truist projects fiscal 2027 revenue of $673M and adjusted EBITDA of $320M, and fiscal 2028 revenue of $716M and adjusted EBITDA of $347M. Doximity reported Q1 FY27 revenue of $156.6M vs $151.7M expected and slightly missed EPS.
2 min read
